Back

HLA-A*01:01 allele vanishing in COVID-19 patients population associated with non-structural epitope abundance in CD8+ T-cell repertoire

Shkurnikov, M.; Nersisyan, S.; Averinskaya, D.; Chekova, M.; Polyakov, F.; Titov, A.; Doroshenko, D.; Vechorko, V.; Tonevitsky, A.

2022-07-10 allergy and immunology
10.1101/2022.07.05.22277214 medRxiv
Show abstract

In mid-2021, the SARS-CoV-2 Delta variant caused the third wave of the COVID-19 pandemic in several countries worldwide. The pivotal studies were aimed at studying changes in the efficiency of neutralizing antibodies to the spike protein. However, much less attention was paid to the T-cell response and the presentation of virus peptides by MHC-I molecules. In this study, we compared the features of the HLA-I genotype in symptomatic patients with COVID-19 in the first and third waves of the pandemic. As a result, we could identify the vanishing of carriers of the HLA-A*01:01 allele in the third wave and demonstrate the unique properties of this allele. Thus, HLA-A*01:01-binding immunoprevalent epitopes are mostly derived from ORF1ab. A set of epitopes from ORF1ab was tested, and their high immunogenicity was confirmed. Moreover, analysis of the results of single-cell phenotyping of T-cells in recovered patients showed that the predominant phenotype in HLA-A*01:01 carriers is central memory T-cells. The predominance of T-lymphocytes of this phenotype may contribute to forming long-term T-cell immunity in carriers of this allele. Our results can be the basis for highly effective vaccines based on ORF1ab peptides.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Cellular & Molecular Immunology
14 papers in training set
Top 0.1%
23.6%
2
Frontiers in Immunology
586 papers in training set
Top 0.5%
10.6%
3
Journal of Medical Virology
137 papers in training set
Top 0.1%
9.6%
4
Allergy
23 papers in training set
Top 0.1%
6.7%
50% of probability mass above
5
Biology
43 papers in training set
Top 0.1%
4.2%
6
Vaccines
196 papers in training set
Top 0.6%
3.8%
7
Journal of Clinical Immunology
11 papers in training set
Top 0.1%
3.8%
8
PLOS ONE
4510 papers in training set
Top 46%
2.5%
9
Journal of Biomedical Science
14 papers in training set
Top 0.1%
2.2%
10
eLife
5422 papers in training set
Top 37%
2.0%
11
Virus Research
36 papers in training set
Top 0.4%
1.9%
12
Scientific Reports
3102 papers in training set
Top 54%
1.9%
13
Emerging Microbes & Infections
74 papers in training set
Top 0.7%
1.8%
14
Journal of Virology
456 papers in training set
Top 2%
1.8%
15
Genes & Immunity
11 papers in training set
Top 0.1%
1.6%
16
iScience
1063 papers in training set
Top 19%
1.4%
17
The Journal of Immunology
146 papers in training set
Top 1%
1.0%
18
Journal of Cellular and Molecular Medicine
18 papers in training set
Top 0.7%
0.9%
19
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
20
Immunology
29 papers in training set
Top 0.8%
0.8%
21
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
22
PLOS Pathogens
721 papers in training set
Top 8%
0.8%
23
Frontiers in Microbiology
375 papers in training set
Top 8%
0.8%
24
Clinical Immunology
21 papers in training set
Top 0.6%
0.8%
25
Cell Discovery
54 papers in training set
Top 5%
0.8%
26
Pharmaceuticals
33 papers in training set
Top 2%
0.8%
27
Cells
232 papers in training set
Top 7%
0.7%
28
Briefings in Bioinformatics
326 papers in training set
Top 7%
0.7%
29
Science China Life Sciences
26 papers in training set
Top 2%
0.7%
30
Protein Science
221 papers in training set
Top 2%
0.5%